V2 Communications adds CarePort Health to its client portfolio

Business Wire | August 26, 2020

V2 Communications (V2), a public relations and digital communications agency for disruptive global brands, has added CarePort Health (CarePort), a market leader in care transitions software, to its client portfolio. CarePort joins companies such as DirectPath and Current Health on V2’s healthcare client roster. CarePort is the leading care coordination network with hospitals, post-acute providers, payers and physician groups connected across the U.S. The end-to-end platform bridges acute and post-acute electronic health record (EHR) data, providing visibility into the entire patient journey for providers, physicians, payers and accountable care organizations (ACOs). Leveraging CarePort, healthcare professionals can efficiently and effectively coordinate patient care to better track and manage patients as they move through the continuum. As the pandemic took hold of the U.S. and the world, V2 was brought in to help CarePort increase brand awareness, showcase the value of its platform and position CarePort as the authoritative voice on today’s most critical healthcare industry issues.

Spotlight

This annual report offers an in-depth look into how healthcare employees, partners, contractors, and customers are adopting secure, reliable new technology to be productive with various apps and services, successfully fueling the industry's evolution.

Spotlight

This annual report offers an in-depth look into how healthcare employees, partners, contractors, and customers are adopting secure, reliable new technology to be productive with various apps and services, successfully fueling the industry's evolution.

Related News

HEALTH TECHNOLOGY

DeepIntent® introduces DeepIntent Outcomes

DeepIntent | April 07, 2021

DeepIntent, the leading healthcare marketing technology company built to influence patient health and business outcomes, today announced DeepIntent Outcomes, which uses real-world clinical evidence to significantly boost script lift attributed to digital advertising. DeepIntent Outcomes, which is built into its Healthcare Demand-Side Platform (DSP), allows advertisers to measure and automatically optimize live promotions based on script performance from pharmaceutical claims data that is updated regularly. DeepIntent Outcomes assists healthcare marketers in solving today's common barriers, such as data silos, the use of multiple channels, and delayed reporting. DeepIntent Outcomes enables marketers to use script performance to reduce waste, improve marketing mix in-flight and: Plan their strategies focused on insights into patients' and providers' in-market behaviors. Enable their media plans for all devices via a single platform; Monitor the effects of each campaign in real-time Optimize campaign efficiency regularly by automatically modifying creative, reach, frequency, publishers, pricing, and bidding strategy. DeepIntent Outcomes promotes the ability to measure the combined impact of patient and provider advertisement on script lift as one of the strategic use cases. DeepIntent Outcomes partnered with Publicis Health Media to coordinate and measure ad exposures to patients and caregivers with one of their leading pharmaceutical clients. Through this new platform, their client's script lift has increased by an average of 10-35 %. Through its collaboration with Komodo Health, DeepIntent Outcomes has access to the industry's most comprehensive, transparent, trusted, and verified healthcare data set, as well as the fastest pharmaceutical data refresh. DeepIntent's healthcare identification graph sees 75% of healthcare providers every day and 86% every month, with a 25% higher overall audience quality for patient campaigns. The combination of these two solutions provides previously unseen capabilities in the pharmaceutical market. DeepIntent was named Best-Buy Side Programmatic Platform by Digiday in 2020, beating out rivals such as Xandr and Verizon Media. About DeepIntent DeepIntent, founded by former Memorial Sloan Kettering data scientists, connects healthcare companies with patients and providers through all devices through proprietary data, media collaborations, and integrations. DeepIntent is seen to increase script lift while enhancing patients' quality of life from across the board, from campaign planning to audience targeting to measuring and maximizing. Its Healthcare Marketing Platform enables marketers at seven of the top ten pharmaceutical companies and major healthcare advertising agencies to have a direct impact on health and business outcomes.

Read More

DIGITAL HEALTHCARE

DayOne launches new call for Digital Health startups

DayOne | October 23, 2021

DayOne, the Healthcare Innovation initiative based in Switzerland, announces the extended deadline for the global call for its digital health accelerator to Friday, 5 November 2021. Startups with a focus on pain therapy can apply to be considered for the DayOne Accelerator by 5 November 2021. DayOne is looking for companies with emerging technologies for pain treatment as well as digital healthcare solutions in pain management. The DayOne Accelerator is the healthcare innovation initiative of Basel Area Business & Innovation and is split into three categories: Digital Health, Tech and Innovation Booster. They support promising new digital health and precision medicine ventures with guidance, mentorship, funding and collaborative workspaces. From 2018, DayOne has supported 20 companies with a combined valuation of over CHF 65 million, contributing to the life sciences ecosystem of the Basel Area. DayOne has helped launch, connect and mentor a number of innovative healthcare ventures, which include companies such as Zoundream and Nutrix in addition to others in medtech, medical device, digital health, AI, nutrition, health monitoring, medical access and more. Building on this success, the DayOne Accelerator is extending its offering – both in terms of content and the area it covers. Going forward, DayOne is opening its accelerator to startups operating in practically all areas of digital health. It will also expand its financial support to allow companies in the fields of prevention, diagnostics and treatment to apply for grants as well. For the Digital Health track, three startups will be considered for the three-month funding program, with each in line to receive a grant of up to CHF 45,000 in funding and services in addition to expert coaching and access to the world leading biopharma ecosystem of the Basel Area. "At DayOne, we believe that the future of health can only evolve if advances in medical and healthcare technologies go hand in hand with innovation across the ecosystem. Today innovation primarily takes place within separate silos, where pharmaceutical companies, healthcare providers and governments have different agendas. Bringing all these areas together in a neutral setting of collaboration is the key to shaping the future of health, building an innovation hub. We are delighted to launch these new calls to encourage innovation in digital health and support entrepreneurs realise their vision while providing much needed solutions for patients." Lucas Scherdel, Director Healthcare Innovation – DayOne DayOne is also announcing calls for its Tech and Innovation Booster verticals, with deadlines in Q1 2022. For the Tech vertical, the focus is on startups in medical robotics, 3D printing, virtual reality in healthcare applications and technological solutions for personalized medicine. The winners will receive financial support of up to CHF 100,000 in funding and services, amongst other benefits including offering of shared offices and access to a world leading medtech and microtechnology network. Finally, the Innovation Booster category supports budding projects in the area of digital health. The focus here is on patient-centric solutions that have been jointly developed by startups in close collaboration with academic partners and Big Pharma. The Innovation Booster category is operated on a nationwide basis, with startups able to submit applications in the first quarter of 2022. In addition to financing support, DayOne helps build out companies and teams from inception to a point where they can raise financing and enter strategic collaborations. Harnessing the Basel Area's unique position as a global healthcare hub, as well as its rising popularity among investors, DayOne is looking to attract the next generation of breakthrough companies. Interested groups can find information at www.dayone.swiss/digitalhealth. DayOne accelerates innovative ventures across three verticals: Digital Health: Pain management track starts Jan 2022 – apply by Nov 5, 2021 Tech: Ventures in medical robotics, virtual reality for healthcare or personalized medical technologies – call opens Q1 2022 Innovation Booster: Empowered by Innosuisse, with a special focus on the interface with big pharma and academia – call opens Q1 2022 About DayOne Accelerator At DayOne, we are shaping the future of health by accelerating digital transformation in Europe's leading healthcare and life sciences hub. As the Healthcare Innovation initiative by Basel Area Business & Innovation, DayOne believes in a patient-centric and sustainable approach to healthcare. Led by a team of industry experts, medical doctors, tech enthusiasts and researchers, the DayOne innovation hub serves a growing community of 2,000+ healthcare innovators throughout the Basel Area life sciences and healthcare ecosystem. The DayOne Accelerator boosts innovative ventures that combine groundbreaking technologies, healthcare expertise, and entrepreneurial spirit. Since 2018, the DayOne Accelerator has supported 20 companies, with a combined valuation of over CHF 65 million. About Basel Area Business & Innovation Basel Area Business & Innovation is the investment and innovation promotion agency dedicated to helping companies, institutions and startups find business success in the Basel Area, Switzerland. The organization targets and attracts companies to settle, supports founders of innovative ventures, and drives high growth initiatives in order to establish the region as the Swiss business and innovation hub of the future. The non-profit agency focuses on growing the area's cutting-edge industries life sciences, healthcare and production technologies.

Read More

NeuPath Health Inc. Announces to Expand Company’s Digital Health Capabilities

NeuPath Health Inc. | October 05, 2020

NeuPath Health Inc. Canada’s largest provider of chronic pain management services, announced today an initiative to expand the Company’s digital health capabilities. Pivot Design Group (“Pivot”) – a leading Toronto boutique strategic design and communications agency specializing in service design, user experience design and communication design – will work with NeuPath, its physicians, healthcare providers, and patients to translate research and insights into proprietary digital health solutions designed to provide chronic pain patients with multi-modal care and the tools needed to live a complete and fulfilled life.

Read More